Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3 instead of v3.6.2, indicating a small maintenance/version update to the page's metadata. This does not modify the substantive study content.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays the site revision as v3.6.2, indicating a deployment update. This change does not modify the displayed study details.
    Difference
    0.1%
    Check dated 2026-06-26T19:34:49.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was standardized and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:03.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label on the page changes from v3.5.4 to v3.5.5. This signals a new build/update of the page content and related assets.
    Difference
    0.1%
    Check dated 2026-06-05T08:29:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a minor backend or CMS update without changing the study details or visible content.
    Difference
    0.1%
    Check dated 2026-05-15T02:09:42.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new clinical study report synopsis item has been added to the Study Documents area, along with sponsor-related entries AbbVie and Helpful Links Provided by AbbVie.
    Difference
    0.2%
    Check dated 2026-05-07T21:47:57.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.